8-K - BioMarin Pharmaceutical Inc. | StockGist

Current Report Details

Event Type

Regulation Fd

Exhibits Only

Disclosure

Voluntary

Variant

8-K

Items Reported

7.01

Regulation FD Disclosure. On January 29, 2026, BioMarin Pharmaceutical Inc. (BioMarin or the company) entered into a purchase agreement (the Purchase Agreement)

Regulation Fd

$850.0M$2.00B$800.0M$600.0M

9.01

Financial Statements and Exhibits. (d) Exhibits. Exhibit Number Description 99.1 Press Release dated January 29, 2026. 104 Cover Page Interactive Data File (emb

Exhibits Only

Source Document

Exhibits (2)

8-K

99.1

EX-99.1